New York Telehealth AI Malpractice in 2026

The frantic call came just after 11 PM. Ms. Eleanor Vance, a 68-year-old retired schoolteacher from the Upper West Side, was in distress. Her daughter, Sarah, explained that Eleanor had been experiencing persistent, severe headaches and intermittent vision disturbances for nearly two weeks. Eleanor had relied on a popular telehealth platform for her routine medical needs since the pandemic, finding it convenient for her mobility issues. A week prior, after her second virtual consultation for these symptoms, the platform’s integrated AI diagnostic tool had suggested a diagnosis of “ocular migraines” and recommended over-the-counter pain relievers. Eleanor followed the advice, but her condition worsened, culminating in a partial loss of vision in her left eye that evening. This case, though fictional, illustrates the emerging and complex legal battleground of New York medical malpractice claims stemming from telehealth AI errors. Can patients truly find recourse when an algorithm, not a human, makes a critical misstep? Eleanor’s initial telehealth appointment involved a video consultation with a physician’s assistant (PA) who input her symptoms into the platform’s AI system. The AI, designed to assist in preliminary diagnoses, cross-referenced Eleanor’s age, reported symptoms, and medical history (which included a family history of migraines) against millions of anonymized patient records. Its output, “ocular migraines, low probability of acute neurological event,” significantly influenced the PA’s subsequent recommendations. What the AI missed, and what the human PA did not sufficiently investigate, was the atypical progression of Eleanor’s symptoms and the absence of a prior migraine history for Eleanor herself.

When Sarah brought her mother to the emergency room at NewYork-Presbyterian Hospital on East 68th Street, the attending neurologist immediately recognized the severity. An urgent MRI revealed a rapidly expanding glioblastoma, a highly aggressive brain tumor, precisely where the AI had dismissed “acute neurological event” as unlikely. The delay in diagnosis, directly attributable to the AI’s misleading assessment and the PA’s reliance on it, drastically reduced Eleanor’s treatment options and prognosis. This scenario raises fundamental questions about accountability. Who is responsible when a sophisticated algorithm provides flawed medical guidance? Is it the physician, the telehealth platform, the AI developer, or a combination?

Understanding Medical Malpractice in the Age of AI

Medical malpractice in New York requires proving several key elements: a duty of care, a breach of that duty, causation, and damages. In traditional settings, the breach typically involves a healthcare provider deviating from the accepted standard of care. With AI, the lines blur. The standard of care itself is evolving. Is a physician expected to override an AI’s recommendation, or can they reasonably rely on its output? “The challenge with AI in medical malpractice is establishing what constitutes a ‘deviation from accepted medical standards’ when the ‘medical professional’ involved is a machine,” explains Dr. Anya Sharma, a bioethicist specializing in AI in healthcare. “We’re not just looking at human error anymore. We’re examining algorithmic bias, data integrity, and the design parameters of the AI itself.” The New York State Department of Health (NYSDOH) provides regulations governing telehealth services, emphasizing that providers remain responsible for the care delivered, regardless of the technology used. This means that while AI can assist, the ultimate responsibility for patient outcomes generally remains with the licensed medical professional. Our firm has seen an increasing number of inquiries related to these novel issues. We advise clients to carefully document every interaction with telehealth platforms, including screenshots of recommendations, chat logs, and recordings of video consultations if permitted. This digital trail becomes invaluable evidence.

Hurt by a medical mistake?

Know what your case is worth with AI Medical Payout Calculator for FREE!

Start my free evaluation

The Role of Telehealth Platforms and AI Developers

In Eleanor’s case, the telehealth platform prominently marketed its AI diagnostic capabilities as a foundation of its efficiency and accuracy. This marketing could establish an implied promise of reliability. If the AI was poorly designed, inadequately tested, or fed biased data, the developer could share liability. Proving this, however, often requires extensive discovery into proprietary algorithms and data sets, a notoriously difficult task. The legal framework for product liability might also apply here. If the AI is viewed as a “product” that is defective and causes harm, then the developer could be held liable under a strict liability theory, meaning fault does not need to be proven. However, courts are still grappling with whether software, particularly diagnostic software, fits neatly into existing product liability definitions. A 2023 article in the New England Journal of Medicine discussed the complexities of attributing liability when AI systems are involved in clinical decision-making, highlighting the need for clearer legal guidelines.

Establishing Causation: A Complex Web

For Eleanor Vance, establishing that the AI error caused her delayed diagnosis requires expert testimony. We would need neurologists to testify that, given her symptoms, a reasonably prudent PA or physician, without the AI’s flawed guidance, would have ordered an MRI sooner. Plus, we would require AI specialists to dissect the algorithm, demonstrating how its design flaws or the data it processed led to the incorrect “ocular migraine” diagnosis. This could involve examining the training data for demographic biases or flaws in how it weighted symptoms. For instance, if the AI was predominantly trained on data from younger patients with migraines, it might have misinterpreted Eleanor’s symptoms, which are more indicative of a tumor in an older demographic. This isn’t theoretical. Studies have shown that AI models can exhibit biases present in their training data, leading to disparities in care. A report from the U.S. Government Accountability Office (GAO) in 2024, for example, detailed concerns about the potential for algorithmic bias in healthcare AI and its impact on patient safety. We would also need to demonstrate that the delay in diagnosis directly led to a worse prognosis for Eleanor. This requires oncologists and neurologists to testify that earlier intervention would have offered more effective treatment options or a longer life expectancy. This is often the most contentious point in any medical malpractice case, and AI only adds layers of technical complexity.

The Physician’s Responsibility: Oversight and Prudence

Despite the AI’s recommendation, the human PA still had a professional obligation to exercise independent medical judgment. New York Education Law Section 6530 outlines professional misconduct for physicians, including negligence and incompetence. While PAs operate under physician supervision, they also carry individual responsibility for their clinical decisions. A physician cannot simply outsource their diagnostic responsibilities to an algorithm. They must understand the AI’s limitations, validate its output against their own clinical knowledge, and, when necessary, order additional tests or seek further consultation. The NYSDOH’s guidance on telehealth reinforces this, stating that the standard of care for telehealth services is the same as for in-person services. This implies that if a reasonable human practitioner would have ordered an MRI for Eleanor, the PA’s failure to do so, even influenced by AI, constitutes a breach of duty. Consider the hypothetical, but very real, scenario: a patient presents with classic appendicitis symptoms. An AI, perhaps due to a rare data anomaly, suggests indigestion. A physician who simply rubber-stamps the AI’s diagnosis without further examination or testing would almost certainly be found negligent. The same principle applies to more complex conditions like Eleanor’s glioblastoma.

Working through the Legal Field in New York

Bringing a medical malpractice claim in New York involves strict procedural requirements. A Certificate of Merit, signed by a physician in the same specialty, must affirm that there is a reasonable basis for the action. For cases involving AI, finding such an expert who understands both clinical medicine and the nuances of AI diagnostics is challenging but not impossible. The New York State Bar Association has hosted numerous seminars on emerging legal issues surrounding AI, indicating a growing awareness within the legal community. The statute of limitations for medical malpractice in New York is generally two years and six months from the date of the malpractice, or from the end of continuous treatment for the same illness, injury, or condition. For Eleanor, the clock would likely start ticking from the date of the PA’s misdiagnosis. Missing this deadline can permanently bar a claim. Our approach in such cases involves a multi-pronged investigation:

1. Clinical Review: Engaging top medical experts to determine if the human provider deviated from the standard of care.
2. Technical Analysis: Collaborating with AI ethicists and data scientists to scrutinize the AI’s design, training data, and decision-making process.
3. Platform Policies: Examining the telehealth platform’s terms of service, disclaimers, and internal protocols regarding AI use and human oversight.
4. Regulatory Compliance: Assessing adherence to NYSDOH telehealth regulations and any specific guidelines for AI in healthcare.

The Future of Accountability

As AI becomes more integrated into healthcare, the legal system will need to adapt. New legislation may be required to define liability specifically for AI errors. Who pays for the harm? Is it the hospital that licensed the AI, the company that developed it, or the individual physician who used it? Or all three? This is a question with significant implications for both patient safety and technological innovation. I believe the answer will likely involve a shared responsibility model, where each party in the chain of care bears some accountability. Developers must ensure their AI is rigorously tested and transparent about its limitations. Healthcare providers must exercise due diligence and independent judgment, using AI as a tool, not a replacement for critical thinking. And telehealth platforms must implement strong oversight mechanisms and clear disclaimers about AI’s role. For Eleanor Vance, the path ahead is difficult. Her family faces daunting medical bills and the emotional toll of a late-stage diagnosis. Their legal battle will not only seek justice for Eleanor but also contribute to shaping the legal precedents for medical malpractice in the digital age, particularly concerning telehealth AI errors. This is a new frontier, and the stakes could not be higher.

Conclusion

The rise of AI in telehealth offers immense potential but also introduces complex questions of liability when errors occur. Patients in New York who suspect medical malpractice due to AI-assisted diagnoses must act swiftly, gather all pertinent documentation, and consult with legal professionals experienced in both healthcare law and emerging technology.